Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

121.55 -1.50 (-1.22%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells

October 12, 2022

You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?

Via TheNewswire.com

Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells ↗

October 11, 2022

You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?

Via Benzinga

The 7 Most Undervalued Mid-Cap Stocks to Buy Now ↗

September 26, 2022

Here are some of the most undervalued mid-cap stocks to buy now.

Via InvestorPlace

Federman & Sherwood Investigates DaVita, Inc. for Data Breach

September 12, 2022

From Federman & Sherwood

Via Business Wire

What 4 Analyst Ratings Have To Say About DaVita ↗

August 19, 2022

Analysts have provided the following ratings for DaVita (NYSE:DVA) within the last quarter:

Via Benzinga

Warren Buffett Stocks: DaVita Inc. ↗

June 23, 2022

At the end of the first quarter, Berkshire owned a staggering 38% of DaVita’s total shares outstanding. That sort of conviction is difficult to ignore, especially from a legend like Buffett.

Via Talk Markets

Rockwell Medical Receives Additional FDA Feedback On Anemia Candidate ↗

June 23, 2022

Via Benzinga

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company ↗

May 26, 2022

Via Benzinga

7 Undervalued Stocks That Everyone Is Missing Out On ↗

August 19, 2022

All of these undervalued stocks have above-average free cash flow yields and should rebound in the longer term.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022 ↗

August 19, 2022

Upgrades

Via Benzinga

Meta Platforms Price Target Cut By This Analyst, Plus BMO Capital Predicts $223 For Salesforce ↗

August 19, 2022

Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading.

Via Benzinga

Recap: DaVita Q2 Earnings ↗

August 01, 2022

DaVita (NYSE:DVA) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings DaVita beat estimated earnings by 10.05%,...

Via Benzinga

Earnings Scheduled For August 1, 2022 ↗

August 01, 2022

Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.

Via Benzinga

Addus HomeCare's Earnings: A Preview ↗

July 29, 2022

Addus HomeCare (NASDAQ:DVA) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Addus HomeCare...

Via Benzinga

Why Shares Of DaVita Are Down Today ↗

July 28, 2022

Shares of DaVita Inc. (NYSE: DVA) are trading lower today in sympathy Fresenius Medical Care AG & Co (NYSE: FMS), which provided a bearish 2022 outlook and withdrew its 2025 targets.

Via Benzinga

12 Stocks Investors Want To See ↗

July 12, 2022

A look at some very inexpensive growth stocks and a few inexpensive dividend growth stocks.

Via Talk Markets

6 Stocks Insiders Are Buying Now ↗

June 28, 2022

These are 6 stocks insiders are buying now. Execs buying shares now want to get in before Q2 earnings come out - a good sign for investors.

Via InvestorPlace

$44 Million Bet On Occidental Petroleum? 3 Stocks Insiders are Buying ↗

June 28, 2022

Although US stocks closed slightly lower on Monday, there were a few notable insider trades.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

7 Dividend Stocks to Buy and Hold Forever ↗

June 27, 2022

Despite rising interest rates, investors continue to like dividend-paying stocks. Here are seven dividend stocks to buy and hold forever.

Via InvestorPlace

Stock Market Rallies As Fed Chief Powell Vows 'Unconditional' Inflation Fight: Weekly Review ↗

June 24, 2022

Stocks rebounded this week, with China EV stocks and medicals among the leaders.

Via Investor's Business Daily

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise ↗

June 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

June 21, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

Via Benzinga

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

DaVita's Return on Invested Capital Overview ↗

May 25, 2022

Pulled from Benzinga Pro data, DaVita (NYSE:DVA) posted Q1 earnings of $205.72 million, an increase from Q4 of 17.53%. Sales dropped to $2.82 billion, a 4.28% decrease between quarters.

Via Benzinga

How to Buy Stocks in a Recession ↗

May 16, 2022

The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward.

Via InvestorPlace

Markets Finish Sharply Higher Amid Ongoing Macro Concerns ↗

May 13, 2022

U.S. indices traded sharply higher Friday following recent weakness. Markets were highly volatile this week, selling off following the April CPI report, which showed worse-than-expected inflation.

Via Benzinga

27 Recession-Resistant Stocks To Look At Now ↗

May 09, 2022

When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not...

Via Benzinga

7 Oversold Stocks That Shouldn’t Be. Buy Them Now. ↗

May 06, 2022

Consider these seven oversold stocks, as fear, uncertainty and doubt have knocked them down to too low a price.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 05, 2022

Gainers

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DaVita HealthCare Partner (NY:DVA)

All News about DaVita HealthCare Partner

Starting at $3.75/week.

Subscribe Today